+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Expansion Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 100 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4986976
UP TO OFF until Sep 30th 2023

The cell expansion market will show rapid growth due to the increasing incidence of chronic diseases, government investments for cell-based research and increasing focus on R&D for cell-based therapies.

The rising prevalence of chronic diseases coupled with increasing research activities for cell-based research is found to be the major factor driving the cell expansion market. Cardiovascular disease (CVD) is the leading cause of mortality worldwide. According to the WHO, an estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths.

There is an increase in the prevalence of cancer patients that results in a large patient pool, which creates an opportunity for the manufacturers to tap and capitalize on the market. Hence there is an increase in the cases of chronic diseases that are expected to drive the overall market. Furthermore, technological advances in cell expansion devices and growth in government investments regarding healthcare issues are the factors propelling the market.

Key Market Trends

Consumables is Expected to be the Largest Growing Segment in the Cell Expansion Market

The consumables segment has been accounted for the largest share of the market and this is mainly due to the high demand during the production of regenerative medicine and rising research activities on stem cells in the biopharmaceutical companies. There is also a constant requirement for new reagents among end-users that helps in market growth. Furthermore, the rising awareness regarding advanced treatment therapies such as personalized medicine is also another driving factor for this segment.

North America is Found Leading the Cell Expansion Market

The increasing incidences of chronic and cell-based diseases and rising geriatric population are the key factors driving the overall market in this region. The rising investment made by the companies as well as the government for cell expansion research is also a factor driving the market in this region.

The Asia Pacific is poised to grow owing to rapidly expanding biotechnology and biopharmaceutical industries, increasing government investments for cancer and stem cell research and rising focus of prominent players on the emerging markets.

Competitive Landscape

There has been a presence of a considerable number of companies that are mainly focusing on agreements and expansions to strengthen its business operations. There are various established business players that are adopting numerous organic and inorganic growth strategies to increase their market share. New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies undertaken by these companies for sustainable growth.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Chronic Diseases
4.2.2 Government Investments for Cell-Based Research
4.2.3 Increasing Focus on R&D for Cell-Based Therapies
4.3 Market Restraints
4.3.1 Ethical Concerns Regarding Research in Cell Biology
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Consumables
5.1.2 Reagents, Media, & Serum
5.1.3 Disposables
5.1.4 Instruments Cell Expansion Supporting Equipment Bioreactors Automated Cell Expansion Systems
5.2 By Cell Type
5.2.1 Human Cells
5.2.2 Animal Cells
5.3 By Application
5.3.1 Regenerative Medicine and Stem Cell Research
5.3.2 Cancer and Cell-Based Research
5.3.3 Other Applications
5.4 By End User
5.4.1 Biotechnology & Biopharmaceutical Companies
5.4.2 Research Institutes
5.4.3 Others
5.5 Geography
5.5.1 North America United States Canada Mexico
5.5.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.5.4 Middle-East and Africa GCC South Africa Rest of Middle East and Africa
5.5.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific, Inc.
6.1.2 Becton, Dickinson and Company
6.1.3 Terumo BCT
6.1.4 Merck KGaA
6.1.5 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
6.1.6 Miltenyi Biotec
6.1.7 Lonza Group LTD.
6.1.8 Stemcell Technologies, Inc.
6.1.9 GE Healthcare
6.1.10 Takara Bio Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Terumo BCT
  • Merck KGaA
  • Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
  • Miltenyi Biotec
  • Lonza Group LTD.
  • Stemcell Technologies, Inc.
  • GE Healthcare
  • Takara Bio Inc.